<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is an <z:hpo ids='HP_0001548'>overgrowth</z:hpo> syndrome associated with <z:hpo ids='HP_0000158'>macroglossia</z:hpo>, <z:hpo ids='HP_0010866'>abdominal wall defects</z:hpo>, <z:hpo ids='HP_0000598'>ear anomalies</z:hpo>, and an increased risk for embryonic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Reported <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk estimates vary between 4% and 21% </plain></SENT>
<SENT sid="2" pm="."><plain>It has been hypothesized that <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> predisposition in BWS is related to the imprinting status of the H19 and LIT1 genes on chromosome 11p15 </plain></SENT>
<SENT sid="3" pm="."><plain>A loss of imprinting (LOI) of H19 implies a higher <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk </plain></SENT>
<SENT sid="4" pm="."><plain>However, a systematic analysis of available data is lacking </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, we performed a review and meta-analysis of reported associations between the imprinting status of the LIT1 and H19 genes and the risk for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in BWS </plain></SENT>
<SENT sid="6" pm="."><plain>Five publications suitable for meta-analysis were identified by electronic database searches </plain></SENT>
<SENT sid="7" pm="."><plain>Sufficient data were available for 402 out of 520 patients </plain></SENT>
<SENT sid="8" pm="."><plain>Patients were divided into four groups based on the imprinting status of H19 and LIT1: group I with LOI of LIT1 (45%); group II with LOI of H19 (9%); group III with LOI of LIT1 and LOI of H19 (21%); and group IV with <z:mpath ids='MPATH_458'>normal</z:mpath> imprinting patterns (26%) </plain></SENT>
<SENT sid="9" pm="."><plain>Differences in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk between groups were studied with random effects meta-analysis </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> occurred in 55 patients </plain></SENT>
<SENT sid="11" pm="."><plain>The odds of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development was significantly lower in group I when compared to group II (OR=0.06; 95% CI: 0.02-0.21) and group III (OR=0.12; 95% CI: 0.04-0.37) </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> risk did not differ significantly between groups II and III (OR=1.40; 95% CI: 0.56-3.50) </plain></SENT>
<SENT sid="13" pm="."><plain>Compared to group IV, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> risk was significantly lower in group I (OR=0.33; 95% CI: 0.12-0.87) and higher in groups II (OR=4.0; 95% CI: 1.5-10.4) and III (OR=2.6; 95% CI: 1.2-5.7) </plain></SENT>
<SENT sid="14" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> incidence rate for group IV was 10.6% (95% CI: 3.6-17.7) </plain></SENT>
<SENT sid="15" pm="."><plain>Calculated absolute risks were 3% for group I, 43% for group II, and 28% for group III, respectively </plain></SENT>
<SENT sid="16" pm="."><plain>No <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> was seen in group I </plain></SENT>
<SENT sid="17" pm="."><plain>In total, other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were seen with comparable frequencies in groups I-III </plain></SENT>
<SENT sid="18" pm="."><plain>The results show a strong association between a LOI of H19 and especially <z:hpo ids='HP_0002667'>Wilms tumor</z:hpo> development in BWS </plain></SENT>
</text></document>